Norihisa Kato

Prof. Norihisa Kato

Hiroshima University (Graduate School of Integrated Sciences for Life)
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1998 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
NKNorihisa Kato
Norihisa Kato
SSSeiji Sato
Seiji Sato
AYAtsushi Yamanaka
Atsushi Yamanaka
HYHideyuki Yamada
Hideyuki Yamada
NFNaozumi Fuwa
Naozumi Fuwa
MNMasakazu Nomura
Masakazu Nomura
This study provided the first evidence for an antioxidant action of the silk protein sericin by showing that sericin suppressed in vitro lipid peroxidation. Furthermore, sericin was found to inhibi...

1 October 2003 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
SZSiqin Zhaorigetu
Siqin Zhaorigetu
NYNoriyuki Yanaka
Noriyuki Yanaka
MSMasahiro Sasaki
Masahiro Sasaki
HWHiromitsu Watanabe
Hiromitsu Watanabe
NKNorihisa Kato
Norihisa Kato

28 February 2002 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
HTHiroyuki Tomotake
Hiroyuki Tomotake
ISIwao Shimaoka
Iwao Shimaoka
JKJun Kayashita
Jun Kayashita
MNMisao Nakajoh
Misao Nakajoh
NKNorihisa Kato
Norihisa Kato

1 November 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PZPeipei Zhang
Peipei Zhang
KTKohsuke Tsuchiya
Kohsuke Tsuchiya
TKTakeshi Kinoshita
Takeshi Kinoshita
HKHiroko Kushiyama
Hiroko Kushiyama
SSSofya Suidasari
Sofya Suidasari
TSTakashi Suda
Takashi Suda
Vitamin B6 includes six water-soluble vitamers: pyridoxal (PL), pyridoxamine (PM), pyridoxine (PN), and their phosphorylated forms. Pyridoxal 5′-phosphate (PLP) is an important cofactor for many metabolic enzymes. Several lines of evidence demonstrate that blood levels of PLP are significantly lower in patients with inflammation than in control subjects and that vitamin B6 has anti-inflammatory effects, with therapeutic potential for a variety of inflammatory diseases. Although one of our group previously demonstrated that PL inhibits the NF-κB pathway, the molecular mechanism by which vitamin B6 suppresses inflammation is not well understood. Here, we showed that both PL and PLP suppressed the expression of cytokine genes in macrophages by inhibiting Toll-like receptor (TLR)-mediated TAK1 phosphorylation and the subsequent NF-κB and JNK activation. Furthermore, PL and PLP abolished NLRP3-dependent caspase-1 processing and the subsequent secretion of mature IL-1β and IL-18 in LPS-primed macrophages. In contrast, PM and PN had little effect on IL-1β production. PLP, but not PL, markedly reduced the production of mitochondrial reactive oxygen species (ROS) in peritoneal macrophages. Importantly, PL and PLP reduced IL-1β production induced by LPS and ATP, or by LPS alone, in mice. Moreover, PL and PLP protected mice from lethal endotoxic shock. Collectively, these findings reveal novel anti-inflammatory activities for vitamin B6 and suggest its potential for preventing inflammatory diseases driven by the NLRP3 inflammasome.

1 July 1997 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
JKJun Kayashita
Jun Kayashita
ISIwao Shimaoka
Iwao Shimaoka
MNMisao Nakajoh
Misao Nakajoh
MYMichikazu Yamazaki
Michikazu Yamazaki
NKNorihisa Kato
Norihisa Kato
Buckwheat protein product (BWP) has a strong hypocholesterolemic activity in rats fed a cholesterol-enriched diet. In this study, we examined the influence of BWP on fecal excretion of sterols and nitrogen in rats fed a diet containing 5 g/kg cholesterol and 1.25 g/kg sodium cholate, and we examined whether the cholesterol-lowering activity of BWP is due to its low digestibility. In Experiment 1, rats fed BWP for 3 wk had significantly lower concentrations of plasma cholesterol and enhanced excretion of fecal total neutral sterols and nitrogen compared with rats fed casein. There was a significant correlation between fecal total neutral sterols and nitrogen (r = 0.89, P < 0.01). Fecal excretion of acidic sterols was unaffected by BWP. In Experiment 2, plasma cholesterol in rats fed trypsin-digested BWP for 2 wk was significantly higher than that in rats fed intact BWP. In Experiment 3, rats were fed BWP, low-molecular-weight fraction of the digest of BWP (LMF ) or high-molecular-weight fraction of the digest of BWP (HMF ) for 3 wk. Plasma cholesterol was lower in the BWP group than in the LMF group (P < 0.05), whereas that in the HMF group was intermediate. The in vitro digestibility of BWP with pepsin and pancreatin was significantly lower than that of casein. The results suggest that the cholesterol-lowering effect of BWP is mediated by higher fecal excretion of neutral sterols and that lower digestibility of BWP is at least partially responsible for the effect.

1 July 2000 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
ISIwao Shimaoka
Iwao Shimaoka
HTHiroyuki Tomotake
Hiroyuki Tomotake
JKJun Kayashita
Jun Kayashita
FYFumiyo Yokoyama
Fumiyo Yokoyama
MNMisao Nakajoh
Misao Nakajoh
NKNorihisa Kato
Norihisa Kato
This study was conducted to investigate the effects of a buckwheat protein product (BWP) on plasma cholesterol, gallbladder bile composition and fecal steroid excretion in hamsters fed diets with 5 g/kg cholesterol. Diets also contained 200 g/kg of casein, soy protein isolate (SPI) or BWP as protein sources. After 2 wk, plasma and liver concentrations of cholesterol in the hamsters fed BWP were significantly lower than those in the hamsters fed casein and SPI. The molar proportion of cholesterol in gallbladder bile was significantly lower in the BWP group than in the other groups, whereas that of bile acids was slightly higher in the BWP group (P ≤ 0.05), resulting in the lowest lithogenic index in the BWP group. None of the hamsters fed BWP had gallstones, whereas they were present in some of the hamsters fed other proteins. Compared with casein intake, BWP intake resulted in significantly higher ratios of cholic acid to chenodeoxycholic acid and of cholic acid to lithocholic acid in the gallbladder bile. The excretions of fecal neutral and acidic steroids were markedly higher in the BWP group compared with the other groups (P ≤ 0.05). SPI intake also significantly lowered cholesterol level in gallbladder bile and caused higher fecal bile acids compared with casein intake, but the effects were significantly less than those of BWP (P ≤ 0.05). The results suggest that BWP suppresses gallstone formation and cholesterol level more strongly than SPI by enhancing bile acid synthesis and fecal excretion of both neutral and acidic steroids.